Rhythm Pharmaceuticals (RYTM) Stock Price, Quote, News & History | Benzinga

SPY—QQQ—BTC/USD—DIA—GLD—TLT—

Rhythm Pharmaceuticals Inc (RYTM) Stock Price, Quote, News & History

RYTMNASDAQ

Trade with Public

Trade with Public

$90.55

2.322.63%

Last update: Oct 20, 1:27 PM

$88.25

0.020.02%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$88.56

Close

-

Volume / Avg.

647.25K / 663.88K

Day Range

$88.56 - $91.88

52 Wk Range

74.50 - 122.20

Market Cap

$6.23B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

15.76%

Days to Cover

14.14

Recent Rhythm Pharmaceuticals, Inc. News

Why Is Rhythm Pharmaceuticals Stock Trading Higher On Wednesday?

Rhythm Pharma shares rise after U.K. expands Imcivree authorization for acquired hypothalamic obesity in adults and children 4 and older.

Vandana Singh

Why Is Rhythm Pharma Stock Jumping Today?

Rhythm Pharma Phase 2 data showed improvements in BMI, body composition, hunger symptoms, and behavior in PWS patients.

Vandana Singh

Rhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 Results

Rhythm Pharmaceuticals (NASDAQ: RYTM) reported better-than-expected earnings, with strong demand for IMCIVREE and potential launches in Europe and Japan.

Avi Kapoor

Rhythm Pharma Wins FDA Approval For First-Ever Rare Weight Disorder Therapy

FDA expands Rhythm Pharmaceuticals Imcivree approval for rare hypothalamic obesity, showing strong weight loss results.

Vandana Singh

Why Playboy Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Playboy (PLBY) shares rise in pre-market trading after reporting better-than-expected Q4 results. Other gainers include PTOR, LNAI, LIDR, ISPC, WNW, JVA, NUAI, XLO, and BW. Losers include PRSO, DFLI, LNSR, and MVST.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-105.35M

Investing Cash Flow (TTM)

-144.94M

Financing Cash Flow (TTM)

179.79M

Free Cash Flow (TTM)

-106.30M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-70.50M

Analyst Trends and Forecast

2

Jul

3

Aug

1

Sep

4

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.87B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

24.82

PB Ratio (TTM)

59.03

Earnings Yield % (TTM)

-3.53%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.50

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$65.61M

Debt to Equity

0.04

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-